High-dose melphalan chemotherapy with autologous stem cell transplant in 63 patients with AL amyloidosis:: Experiences in a centre

被引：0
|
作者：
Schoenland, S.
Hegenbart, U.
Dengler, J.
Bochtler, T.
Hundemer, M.
Singer, R.
Hund, E.
Beimler, J.
Zeier, M.
Kristen, A.
Dengler, T.
Ho, A.
Goldschmidt, H.
机构：
[1] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany
[2] Univ Klinikum Heidelberg, Chirurg Klin, Heidelberg, Germany
[3] Univ Klinikum Heidelberg, Neurol Klin, Heidelberg, Germany
[4] Univ Klinikum Heidelberg, Nierenzentrum, Heidelberg, Germany
[5] Univ Klinikum Heidelberg, Med Klin 3, Heidelberg, Germany
来源：
MEDIZINISCHE KLINIK | 2006年 / 101卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：864 / 865
页数：2
相关论文
共 50 条
  • [41] Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis
    V Sanchorawala
    D G Wright
    K Quillen
    K T Finn
    L M Dember
    J L Berk
    G Doros
    C Fisher
    M Skinner
    D C Seldin
    Bone Marrow Transplantation, 2007, 40 : 557 - 562
  • [42] High-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis: NYHA stage and number of involved organs are predictable for proceeding to high-dose therapy
    Schonland, S
    Hegenbart, U
    Dengler, J
    Benner, A
    Hundemer, M
    Bochtler, T
    Ho, A
    Goldschmidt, H
    BONE MARROW TRANSPLANTATION, 2006, 37 : S6 - S6
  • [43] Patients with AL amyloidosis treated with VAD followed by high dose melphalan and autologous stem cell transplantation
    van Gemeren, II
    Hazenberg, BPC
    Jager, PL
    Smit, JW
    Vellenga, E
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S122 - S122
  • [44] Patients with AL amyloidosis treated with VAD followed by high dose melphalan and autologous stem cell transplantation
    van Gameren, II
    Hazenberg, BPC
    Jager, PL
    Smit, JW
    Vellenga, E
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 76 - 77
  • [45] High Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
    Sanchorawala, Vaishali
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (06) : 1131 - +
  • [46] Engraftment Kinetics after High-Dose Melphalan Autologous Stem Cell Transplant in Patients with Multiple Myeloma
    Bachier-Rodriguez, Lizamarie
    Shah, Gunjan L.
    Knezevic, Andrea
    Devlin, Sean M.
    Maloy, Molly
    Koehne, Guenther
    Chung, David J.
    Landau, Heather
    Giralt, Sergio A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S142 - S143
  • [47] Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation
    Osamu Yamazaki
    Yoshifumi Ubara
    Tatsuya Suwabe
    Shohei Nakanishi
    Junichi Hoshino
    Naoki Sawa
    Noriko Hayami
    Masayuki Yamanouchi
    Fumi Takemoto
    Takaichi Kenmei
    Kazuhiro Masuoka
    Kenichi Oohashi
    Clinical and Experimental Nephrology, 2009, 13 : 522 - 525
  • [48] Successful treatment of AL amyloidosis patients over age 65 with high-dose melphalan and autologous stem cell transplantation (HDM/SCT).
    Seldin, DC
    Anderson, JJ
    Skinner, M
    Malek, K
    Wright, DG
    Quillen, K
    Sanchorawala, V
    BLOOD, 2004, 104 (11) : 264A - 264A
  • [49] Retrospective Analysis of Nursing Interventions and Supportive Care for the Patients with AL Amyloidosis Receiving High-Dose Melphalan and Autologous Stem Cell Transplantation
    Fukumoto, Mihoko
    Tartabe, Satomi
    Kawashima, Sachiko
    Saitoh, Ayumi
    Kawakami, Junko
    Tsukada, Nobuhiro
    Suzuki, Kenshi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S447 - S448
  • [50] Bortezomib and high-dose melphalan with stem cell transplantation for AL amyloidosis: a pilot study
    Sanchorawala, V.
    Quillen, K.
    Sloan, J. M.
    Andrea, N. T.
    Finn, K. T.
    Seldin, D. C.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 186 - 186
12345